Evidence map›Paper›PMID 41858925›Full record

ArticleJHLT open2026

One-year clinical, radiological, and functional outcomes following antifungal therapy for aspergillus infection in lung transplant recipients.

Ariane Lelièvre, Marlène Murris, Marion Dupuis, Jean Mourlanette, Aurélie Le Borgne, Samia Collot, Olivier Marion, Nassim Kamar, Nicolas Guibert, Thomas Villeneuve

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ariane LelièvrePulmonology Department, Toulouse University Hospital, Toulouse, France.
Marlène MurrisRespiratory Medicine Department, University Hospital, Toulouse, France.
Marion DupuisRespiratory Medicine Department, University Hospital, Toulouse, France.
Jean MourlanetteRespiratory Medicine Department, University Hospital, Toulouse, France.
Aurélie Le BorgneRespiratory Medicine Department, University Hospital, Toulouse, France.
Samia CollotRadiology Department, University Hospital, Toulouse, France.
Olivier MarionDepartment of Nephrology and Organ Transplantation, Toulouse University Hospital, INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Université de Toulouse, France.
Nassim KamarDepartment of Nephrology and Organ Transplantation, Toulouse University Hospital, INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Université de Toulouse, France.
Nicolas GuibertRespiratory Medicine Department, University Hospital, Toulouse, France.
Thomas VilleneuveRespiratory Medicine Department, University Hospital, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We conducted a retrospective study of all adult lung transplant recipients followed at Toulouse University Hospital from 2014 to 2024. Patients were stratified as Results: Among 174 patients, 46% were Conclusion: In our cohort, patients treated for

Indexed as

AspergillosisAspergillusLung Transplantation

Identifiers

PMID41858925
PMCPMC12996668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.